• Keynote 695 Clinical Trial
  • Advancing OncoSec
OncoSec logo OncoSec mobile logo
  • ABOUT
    • About
    • Join the Team
    • Management Team
  • PIPELINE
  • TECHNOLOGY
    • Technology
    • TAVO
    • Combination Approach
    • Publications
  • PARTNERING
  • PATIENTS
    • Patients
    • Resources
    • Expanded Access
  • INVESTORS
  • MEDIA
  • CONTACT

Quote

Investors

Investors

  • Overview
    • Profile
    • Contacts
  • Events & Presentations
  • Analysts
  • Press Releases
    • Email Alerts
  • Financial Info
  • Stock Info
    • Quote
    • Charts
    • Historical Data
  • Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • FAQ
  • Stock Info

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Contacts
  • RSS News Feed
footer logo

Sign Up for our mailing list to stay current on all of our exciting new research and developments.

Get Email Alerts

Links

  • ABOUT
  • PIPELINE
  • TECHNOLOGY
  • PARTNERING
  • PATIENTS
  • INVESTORS
  • MEDIA & EVENTS
  • CONTACT
  • KEYNOTE 695 CLINICAL TRIAL

Contact

New Jersey Headquarters
24 N. Main St
Pennington, NJ 08534

R&D Laboratories
3565 General Atomics Court #100
San Diego, CA 92121

p | 855.622.6732

f | 858.430.3832

Investors@OncoSec.com

© 2019 OncoSec Medical Incorporated. All Rights Reserved. Q12-003052-01 REV E. OncoSec’s investigational products have not been approved or cleared by the FDA.

Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.